Evidence map›Paper›PMID 30179226›Full record

ArticleThe Journal of clinical investigation2018

REVERBa couples the circadian clock to hepatic glucocorticoid action.

Giorgio Caratti, Mudassar Iqbal, Louise Hunter, Donghwan Kim, Ping Wang, Ryan M Vonslow, Nicola Begley, Abigail J Tetley, Joanna L Woodburn, Marie Pariollaud and 16 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Avian migration clocks in a changing world.Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Hepatitis B and circadian rhythm of the liver.World journal of gastroenterology · 2022
    Review
  18. Circadian clock function does not require the histone methyltransferase MLL3.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 4 institutions in 2 countries.

Giorgio CarattiFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Mudassar IqbalFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Louise HunterFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Donghwan KimLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Ping WangFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Ryan M VonslowFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Nicola BegleyFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Abigail J TetleyFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Joanna L WoodburnFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Marie PariollaudFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Robert MaidstoneFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Ian J DonaldsonFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Zhenguang ZhangFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Louise M InceFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Gareth KitchenFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Matthew BaxterFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Toryn M PoolmanFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Dion A DanielsBiopharmaceutical Molecular Discovery, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom.
David R StirlingBiopharmaceutical Molecular Discovery, GlaxoSmithKline, Medicines Research Centre, Stevenage, United Kingdom.
Chad BrockerLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Frank GonzalezLaboratory of Metabolism, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Andrew Si LoudonFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
David A BechtoldFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Magnus RattrayFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Laura C MatthewsFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
David W RayFaculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, and Specialist Medicine, Central Manchester Foundation Trust, Manchester, United Kingdom.
Manchester Academic Health Science Centre · GBNational Cancer Institute · USGlaxoSmithKline (United Kingdom) · GBUniversity of Leeds · GB

Funding

Xenobiotic receptorsZIABC005562 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2025
$26.9M
Medical Research Council MR/M008908/1Medical Research Council MR/N002024/1Medical Research Council MR/N021479/1Medical Research Council MR/P00279X/1Medical Research Council MR/P011853/1Medical Research Council MR/P011853/2Medical Research Council MR/P023576/1Wellcome Trust 107851/Z/15/Z
6 · The paper itself

Abstract

The glucocorticoid receptor (GR) is a major drug target in inflammatory disease. However, chronic glucocorticoid (GC) treatment leads to disordered energy metabolism, including increased weight gain, adiposity, and hepatosteatosis - all programs modulated by the circadian clock. We demonstrated that while antiinflammatory GC actions were maintained irrespective of dosing time, the liver was significantly more GC sensitive during the day. Temporal segregation of GC action was underpinned by a physical interaction of GR with the circadian transcription factor REVERBa and co-binding with liver-specific hepatocyte nuclear transcription factors (HNFs) on chromatin. REVERBa promoted efficient GR recruitment to chromatin during the day, acting in part by maintaining histone acetylation, with REVERBa-dependent GC responses providing segregation of carbohydrate and lipid metabolism. Importantly, deletion of Reverba inverted circadian liver GC sensitivity and protected mice from hepatosteatosis induced by chronic GC administration. Our results reveal a mechanism by which the circadian clock acts through REVERBa in liver on elements bound by HNF4A/HNF6 to direct GR action on energy metabolism.

Indexed as

AnimalsChromatinCircadian ClocksEnergy MetabolismFatty LiverGlucocorticoidsHEK293 CellsHumansLiverMiceMice, KnockoutNuclear Receptor Subfamily 1, Group D, Member 1Receptors, GlucocorticoidChromatinGlucocorticoidsNr1d1 protein, mouseNuclear Receptor Subfamily 1, Group D, Member 1Receptors, GlucocorticoidEndocrinologyMetabolismTranscription

Identifiers

PMID30179226
PMCPMC6160001
OpenAlexW2892155992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.